Drug intelligence / Profile preview

UCL Stem Cell Therapy

Development stage
Preclinical
Lead developer
University College London
Modality
Stem Cell Therapies → Cell Therapies
Administration
Ophthalmic
01

Overview

CellResearch Corporation's UCL Stem Cell Therapy is an allogeneic cell-based regenerative treatment utilizing stem cells derived from the umbilical cord lining (UCLSCs). These cells are characterized by the expression of CD227 and a unique pattern of P63 expression. The therapy is specifically developed for corneal resurfacing and repair, targeting conditions such as corneal scarring or fogging that lead to vision loss. Developed in collaboration with the Singapore National Eye Centre (SNEC) and the Vietnam National Eye Institute, the treatment involves transplanting these stem cells, often on an amniotic membrane carrier, to regenerate damaged corneal tissue. This approach aims to provide a regenerative alternative to traditional corneal transplants by restoring the ocular surface's integrity and clarity.

Other names
Umbilical Cord Lining Stem Cell TherapyUCLSC therapyUCL Stem Cell Therapy (Corneal)

Beyond the preview

Go deeper on UCL Stem Cell Therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UCL Stem Cell Therapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call